Trials / Completed
CompletedNCT05926089
Acute Phase Reactant in Non-COVID-19 Bacterial Pneumonia
Acute Phase Reactant in Non-COVID-19 Community Acquired Pneumonia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 51 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is a cross-sectional study, was conducted at Chest department of Kasr Al-ainy Hospital, Cairo university during the period between October 2020 and April 2021. The aim of the work was to evaluate levels of acute phase reactants(APR) in Non-COVID-19 bacterial pneumonia, and to correlate between levels of APR and the disease severity.
Detailed description
51 patients were included in our study, diagnosed as Non-COVID pneumonia Inclusion criteria: 1. PCR(polymerase chain reaction) negative for COVID. 2. All patients of both sexes with pneumonia . Exclusion criteria: 1. Non pulmonary infections. 2. Post surgery patients. 3. Renal patients. 4. hepatic patients. 5. Cardiac patients. 6. Recent pulmonary embolism. Methodology in details: All patients were subjected to: 1. Full history with emphasis on: * Epidemiological features (age, gender). * Risk factors (smoking, DM). * Clinical presentation (cough, Fever and duration of illness). 2. Clinical examination (local chest examination). 3. Laboratory investigations: venous blood samples were taken to measure APR
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood sampling | blood sampling to measure APR |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2021-04-30
- Completion
- 2021-05-30
- First posted
- 2023-07-03
- Last updated
- 2023-07-14
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05926089. Inclusion in this directory is not an endorsement.